Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2001 Mar;109(3):245–251. doi: 10.1289/ehp.01109245

Arsenic alters the function of the glucocorticoid receptor as a transcription factor.

R C Kaltreider 1, A M Davis 1, J P Lariviere 1, J W Hamilton 1
PMCID: PMC1240242  PMID: 11333185

Abstract

Chronic human exposure to nonovertly toxic doses of arsenic is associated with an increased risk of cancer. Although its carcinogenic mechanism is still unknown, arsenic does not directly cause DNA damage or mutations and is therefore thought to act principally as a co-mutagen, co-carcinogen, and/or tumor promoter. Previous studies in our laboratory demonstrated that effects of low-dose arsenic (III) (arsenite) on expression of the hormone-regulated phosphoenolpyruvate carboxykinase (PEPCK) gene were strongly associated with the glucocorticoid receptor (GR)-mediated regulatory pathway. We therefore examined specifically the effects of arsenite on the biochemical function of GR in hormone-responsive H4IIE rat hepatoma cells. Completely noncytotoxic arsenite treatments (0.3-3.3 microM) significantly decreased dexamethasone-induced expression of transiently transfected luciferase constructs containing either an intact hormone-responsive promoter from the mammalian PEPCK gene or two tandem glucocorticoid response elements (GRE). Western blotting and confocal microscopy of a green fluorescent protein-tagged-GR fusion protein demonstrated that arsenite pretreatment did not block the normal dexamethasone-induced nuclear translocation of GR. These data indicate that nontoxic doses of arsenite can interact directly with GR complexes and selectively inhibit GR-mediated transcription, which is associated with altered nuclear function rather than a decrease in hormone-induced GR activation or nuclear translocation.

Full Text

The Full Text of this article is available as a PDF (112.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abernathy C. O., Liu Y. P., Longfellow D., Aposhian H. V., Beck B., Fowler B., Goyer R., Menzer R., Rossman T., Thompson C. Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect. 1999 Jul;107(7):593–597. doi: 10.1289/ehp.99107593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barnes P. J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 1998 Jun;94(6):557–572. doi: 10.1042/cs0940557. [DOI] [PubMed] [Google Scholar]
  3. Beato M., Chávez S., Truss M. Transcriptional regulation by steroid hormones. Steroids. 1996 Apr;61(4):240–251. doi: 10.1016/0039-128x(96)00030-x. [DOI] [PubMed] [Google Scholar]
  4. Beato M., Sánchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. Endocr Rev. 1996 Dec;17(6):587–609. doi: 10.1210/edrv-17-6-587. [DOI] [PubMed] [Google Scholar]
  5. Beato M., Truss M., Chávez S. Control of transcription by steroid hormones. Ann N Y Acad Sci. 1996 Apr 30;784:93–123. doi: 10.1111/j.1749-6632.1996.tb16231.x. [DOI] [PubMed] [Google Scholar]
  6. Bradshaw M. S., Tsai M. J., O'Malley B. W. A steroid response element can function in the absence of a distal promoter. Mol Endocrinol. 1988 Dec;2(12):1286–1293. doi: 10.1210/mend-2-12-1286. [DOI] [PubMed] [Google Scholar]
  7. Budunova I. V., Carbajal S., Kang H., Viaje A., Slaga T. J. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis. Mol Carcinog. 1997 Mar;18(3):177–185. [PubMed] [Google Scholar]
  8. Carey K. L., Richards S. A., Lounsbury K. M., Macara I. G. Evidence using a green fluorescent protein-glucocorticoid receptor chimera that the Ran/TC4 GTPase mediates an essential function independent of nuclear protein import. J Cell Biol. 1996 Jun;133(5):985–996. doi: 10.1083/jcb.133.5.985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cato A. C., König H., Ponta H., Herrlich P. Steroids and growth promoting factors in the regulation of expression of genes and gene networks. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):63–68. doi: 10.1016/0960-0760(92)90188-o. [DOI] [PubMed] [Google Scholar]
  10. Cavanaugh A. H., Simons S. S., Jr Glucocorticoid receptor binding to calf thymus DNA. 1. Identification and characterization of a macromolecular factor involved in receptor-steroid complex binding to DNA. Biochemistry. 1990 Jan 30;29(4):989–996. doi: 10.1021/bi00456a022. [DOI] [PubMed] [Google Scholar]
  11. Cavanaugh A. H., Simons S. S., Jr Glucocorticoid receptor binding to calf thymus DNA. 2. Role of a DNA-binding activity factor in receptor heterogeneity and a multistep mechanism of receptor activation. Biochemistry. 1990 Jan 30;29(4):996–1002. doi: 10.1021/bi00456a023. [DOI] [PubMed] [Google Scholar]
  12. Chakraborti P. K., Hoeck W., Groner B., Simons S. S., Jr Localization of the vicinal dithiols involved in steroid binding to the rat glucocorticoid receptor. Endocrinology. 1990 Nov;127(5):2530–2539. doi: 10.1210/endo-127-5-2530. [DOI] [PubMed] [Google Scholar]
  13. Chen J. D., Li H. Coactivation and corepression in transcriptional regulation by steroid/nuclear hormone receptors. Crit Rev Eukaryot Gene Expr. 1998;8(2):169–190. doi: 10.1615/critreveukargeneexpr.v8.i2.40. [DOI] [PubMed] [Google Scholar]
  14. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dong Y., Aronsson M., Gustafsson J. A., Okret S. The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response. J Biol Chem. 1989 Aug 15;264(23):13679–13683. [PubMed] [Google Scholar]
  16. Droms K. A., Hanson L. A., Malkinson A. M., Beer D. G. Altered dexamethasone responsiveness and loss of growth control in tumorigenic mouse lung cell lines. Int J Cancer. 1993 Apr 1;53(6):1017–1022. doi: 10.1002/ijc.2910530627. [DOI] [PubMed] [Google Scholar]
  17. Droms K. A., Malkinson A. M. Mechanisms of glucocorticoid involvement in mouse lung tumorigenesis. Exp Lung Res. 1991 Mar-Apr;17(2):359–370. doi: 10.3109/01902149109064424. [DOI] [PubMed] [Google Scholar]
  18. Faber S., O'Brien R. M., Imai E., Granner D. K., Chalkley R. Dynamic aspects of DNA/protein interactions in the transcriptional initiation complex and the hormone-responsive domains of the phosphoenolpyruvate carboxykinase promoter in vivo. J Biol Chem. 1993 Nov 25;268(33):24976–24985. [PubMed] [Google Scholar]
  19. Granner D., O'Brien R., Imai E., Forest C., Mitchell J., Lucas P. Complex hormone response unit regulating transcription of the phosphoenolpyruvate carboxykinase gene: from metabolic pathways to molecular biology. Recent Prog Horm Res. 1991;47:319–348. doi: 10.1016/b978-0-12-571147-0.50014-7. [DOI] [PubMed] [Google Scholar]
  20. Göttlicher M., Heck S., Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J Mol Med (Berl) 1998 Jun;76(7):480–489. doi: 10.1007/s001090050242. [DOI] [PubMed] [Google Scholar]
  21. Hamilton J. W., Kaltreider R. C., Bajenova O. V., Ihnat M. A., McCaffrey J., Turpie B. W., Rowell E. E., Oh J., Nemeth M. J., Pesce C. A. Molecular basis for effects of carcinogenic heavy metals on inducible gene expression. Environ Health Perspect. 1998 Aug;106 (Suppl 4):1005–1015. doi: 10.1289/ehp.98106s41005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hanson L. A., Nuzum E. O., Jones B. C., Malkinson A. M., Beer D. G. Expression of the glucocorticoid receptor and K-ras genes in urethan-induced mouse lung tumors and transformed cell lines. Exp Lung Res. 1991 Mar-Apr;17(2):371–387. doi: 10.3109/01902149109064425. [DOI] [PubMed] [Google Scholar]
  23. Hoeck W., Rusconi S., Groner B. Down-regulation and phosphorylation of glucocorticoid receptors in cultured cells. Investigations with a monospecific antiserum against a bacterially expressed receptor fragment. J Biol Chem. 1989 Aug 25;264(24):14396–14402. [PubMed] [Google Scholar]
  24. Hofmann J., Kaiser U., Maasberg M., Havemann K. Glucocorticoid receptors and growth inhibitory effects of dexamethasone in human lung cancer cell lines. Eur J Cancer. 1995 Nov;31A(12):2053–2058. doi: 10.1016/0959-8049(95)00431-9. [DOI] [PubMed] [Google Scholar]
  25. Ihnat M. A., Lariviere J. P., Warren A. J., La Ronde N., Blaxall J. R., Pierre K. M., Turpie B. W., Hamilton J. W. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents. Clin Cancer Res. 1997 Aug;3(8):1339–1346. [PubMed] [Google Scholar]
  26. Imai E., Miner J. N., Mitchell J. A., Yamamoto K. R., Granner D. K. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem. 1993 Mar 15;268(8):5353–5356. [PubMed] [Google Scholar]
  27. Imai E., Stromstedt P. E., Quinn P. G., Carlstedt-Duke J., Gustafsson J. A., Granner D. K. Characterization of a complex glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol. 1990 Sep;10(9):4712–4719. doi: 10.1128/mcb.10.9.4712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Janknecht R., Hunter T. Versatile molecular glue. Transcriptional control. Curr Biol. 1996 Aug 1;6(8):951–954. doi: 10.1016/s0960-9822(02)00636-x. [DOI] [PubMed] [Google Scholar]
  29. Janssen Y. M., Barchowsky A., Treadwell M., Driscoll K. E., Mossman B. T. Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells. Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8458–8462. doi: 10.1073/pnas.92.18.8458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kaiser U., Hofmann J., Schilli M., Wegmann B., Klotz U., Wedel S., Virmani A. K., Wollmer E., Branscheid D., Gazdar A. F. Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. Int J Cancer. 1996 Jul 29;67(3):357–364. doi: 10.1002/(SICI)1097-0215(19960729)67:3<357::AID-IJC9>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
  31. Kaltreider R. C., Pesce C. A., Ihnat M. A., Lariviere J. P., Hamilton J. W. Differential effects of arsenic(III) and chromium(VI) on nuclear transcription factor binding. Mol Carcinog. 1999 Jul;25(3):219–229. [PubMed] [Google Scholar]
  32. Karagas M. R., Tosteson T. D., Blum J., Morris J. S., Baron J. A., Klaue B. Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect. 1998 Aug;106 (Suppl 4):1047–1050. doi: 10.1289/ehp.98106s41047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell. 1998 May 15;93(4):487–490. doi: 10.1016/s0092-8674(00)81177-0. [DOI] [PubMed] [Google Scholar]
  34. Klaue B., Blum J. D. Trace analyses of arsenic in drinking water by inductively coupled plasma mass spectrometry: high resolution versus hydride generation. Anal Chem. 1999 Apr 1;71(7):1408–1414. doi: 10.1021/ac980846+. [DOI] [PubMed] [Google Scholar]
  35. Kresch M. J., Gross I. The biochemistry of fetal lung development. Clin Perinatol. 1987 Sep;14(3):481–507. [PubMed] [Google Scholar]
  36. Kumar M. V., Tindall D. J. Transcriptional regulation of the steroid receptor genes. Prog Nucleic Acid Res Mol Biol. 1998;59:289–306. doi: 10.1016/s0079-6603(08)61035-1. [DOI] [PubMed] [Google Scholar]
  37. Lai M. S., Hsueh Y. M., Chen C. J., Shyu M. P., Chen S. Y., Kuo T. L., Wu M. M., Tai T. Y. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidemiol. 1994 Mar 1;139(5):484–492. doi: 10.1093/oxfordjournals.aje.a117031. [DOI] [PubMed] [Google Scholar]
  38. Lopez S., Miyashita Y., Simons S. S., Jr Structurally based, selective interaction of arsenite with steroid receptors. J Biol Chem. 1990 Sep 25;265(27):16039–16042. [PubMed] [Google Scholar]
  39. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P. The nuclear receptor superfamily: the second decade. Cell. 1995 Dec 15;83(6):835–839. doi: 10.1016/0092-8674(95)90199-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. McCaffrey J., Hamilton J. W. Comparison of effects of direct-acting DNA methylating and ethylating agents on inducible gene expression in vivo. Environ Mol Mutagen. 1994;23(3):164–170. doi: 10.1002/em.2850230303. [DOI] [PubMed] [Google Scholar]
  41. McKenna N. J., Xu J., Nawaz Z., Tsai S. Y., Tsai M. J., O'Malley B. W. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):3–12. doi: 10.1016/s0960-0760(98)00144-7. [DOI] [PubMed] [Google Scholar]
  42. Parks L. L., Turney M. K., Detera-Wadleigh S., Kovacs W. J. An ACTH-producing small cell lung cancer expresses aberrant glucocorticoid receptor transcripts from a normal gene. Mol Cell Endocrinol. 1998 Jul 25;142(1-2):175–181. doi: 10.1016/s0303-7207(98)00107-5. [DOI] [PubMed] [Google Scholar]
  43. Ray D. W., Littlewood A. C., Clark A. J., Davis J. R., White A. Human small cell lung cancer cell lines expressing the proopiomelanocortin gene have aberrant glucocorticoid receptor function. J Clin Invest. 1994 Apr;93(4):1625–1630. doi: 10.1172/JCI117143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Richardson J., Vinson C., Bodwell J. Cyclic adenosine-3',5'-monophosphate-mediated activation of a glutamine synthetase composite glucocorticoid response element. Mol Endocrinol. 1999 Apr;13(4):546–554. doi: 10.1210/mend.13.4.0268. [DOI] [PubMed] [Google Scholar]
  45. Sasaki K., Cripe T. P., Koch S. R., Andreone T. L., Petersen D. D., Beale E. G., Granner D. K. Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. J Biol Chem. 1984 Dec 25;259(24):15242–15251. [PubMed] [Google Scholar]
  46. Scott D. K., Strömstedt P. E., Wang J. C., Granner D. K. Further characterization of the glucocorticoid response unit in the phosphoenolpyruvate carboxykinase gene. The role of the glucocorticoid receptor-binding sites. Mol Endocrinol. 1998 Apr;12(4):482–491. doi: 10.1210/mend.12.4.0090. [DOI] [PubMed] [Google Scholar]
  47. Simons S. S., Jr, Chakraborti P. K., Cavanaugh A. H. Arsenite and cadmium(II) as probes of glucocorticoid receptor structure and function. J Biol Chem. 1990 Feb 5;265(4):1938–1945. [PubMed] [Google Scholar]
  48. Simons S. S., Jr, Pratt W. B. Glucocorticoid receptor thiols and steroid-binding activity. Methods Enzymol. 1995;251:406–422. doi: 10.1016/0076-6879(95)51144-x. [DOI] [PubMed] [Google Scholar]
  49. Spiegelman V. S., Budunova I. V., Carbajal S., Slaga T. J. Resistance of transformed mouse keratinocytes to growth inhibition by glucocorticoids. Mol Carcinog. 1997 Sep;20(1):99–107. [PubMed] [Google Scholar]
  50. Sutherland C., Tebbey P. W., Granner D. K. Oxidative and chemical stress mimic insulin by selectively inhibiting the expression of phosphoenolpyruvate carboxykinase in hepatoma cells. Diabetes. 1997 Jan;46(1):17–22. doi: 10.2337/diab.46.1.17. [DOI] [PubMed] [Google Scholar]
  51. Tsai M. J., O'Malley B. W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem. 1994;63:451–486. doi: 10.1146/annurev.bi.63.070194.002315. [DOI] [PubMed] [Google Scholar]
  52. Wattenberg L. W., Estensen R. D. Studies of chemopreventive effects of budenoside on benzo[a]pyrene-induced neoplasia of the lung of female A/J mice. Carcinogenesis. 1997 Oct;18(10):2015–2017. doi: 10.1093/carcin/18.10.2015. [DOI] [PubMed] [Google Scholar]
  53. Wattenberg L. W., Wiedmann T. S., Estensen R. D., Zimmerman C. L., Steele V. E., Kelloff G. J. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res. 1997 Dec 15;57(24):5489–5492. [PubMed] [Google Scholar]
  54. de Waal R. M. The anti-inflammatory activity of glucocorticoids. Mol Biol Rep. 1994 Mar;19(2):81–88. doi: 10.1007/BF00997151. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES